Can I Take Zepbound (Tirzepatide) While Pregnant?
Key takeaways
Tirzepatide is contraindicated in pregnancy with no safe trimester or dose window.
Animal studies showed serious fetal harms, making the contraindication firm even without human trials.
Women who conceived while on tirzepatide should stop it and call their provider the same day.
Stopping tirzepatide at least one month before trying to conceive is the recommended preconception approach.
Restarting tirzepatide after delivery or while breastfeeding requires direct medical supervision and timing.
Is It Safe to Take Tirzepatide While Pregnant?
If you are pregnant or trying to conceive, tirzepatide is not safe to take, and there is no trimester or dose that changes that. Both Zepbound and Mounjaro use the same active ingredient, and neither is approved for use during pregnancy. This is a firm stop, not a gray area, and knowing that early gives you time to plan well.
Animal studies found serious fetal harm at doses close to what humans use therapeutically, and no controlled human pregnancy trials exist or are likely to be conducted for ethical reasons. The drug's core mechanism, reducing appetite and caloric intake, also works directly against what a growing fetus needs. If you discovered a pregnancy while on tirzepatide, that is stressful news, but it comes with a clear set of steps.
What Does the Research Actually Show?
Human pregnancy data on tirzepatide is limited to accidental exposures reported after the drug reached the market. The more structured evidence comes from animal studies, and those findings are concerning enough to drive the current contraindication.
In rats and rabbits, tirzepatide at doses comparable to human therapeutic levels was linked to:
- Fetal growth restriction: Babies that were significantly smaller than expected
- Skeletal malformations: Structural abnormalities in developing bones
- Increased fetal death: Higher rates of pregnancy loss compared to controls
Beyond the animal data, the drug's basic pharmacology raises concerns. Pregnancy increases caloric and nutritional demands substantially. A medication that suppresses hunger and intake is, by design, working against those demands. No workaround or dose adjustment resolves that fundamental conflict.
What Should You Do If You Got Pregnant While Taking Zepbound?
Do not wait for your next scheduled appointment. Stop tirzepatide immediately and call your OB/GYN or prescribing provider the same day you get a positive test.
Here is the sequence most providers will follow:
- Confirm the pregnancy and gestational age, which determines how much exposure may have occurred
- Discuss fetal monitoring, including whether a detailed ultrasound is appropriate given the timing
- Report the exposure to the Eli Lilly pregnancy registry at 1-800-545-5979, which collects post-market safety data on accidental exposures
It is worth saying clearly: discovering this does not mean the worst outcome is guaranteed. It means close monitoring is warranted, and your provider can help you understand what that looks like for your specific situation. Acting quickly is what matters most.
How Long Before Trying to Conceive Should You Stop?
Eli Lilly's current guidance recommends stopping tirzepatide at least one month before attempting to conceive. The drug has a half-life (the time it takes for half the drug to leave your body) of roughly five days, so one month provides a reasonable clearance window.
Many clinicians recommend a longer washout period of two to three months. This allows time not just for the drug to clear, but for hormonal and nutritional patterns to restabilize before pregnancy places additional demands on your body.
If you have been taking tirzepatide for a condition like PCOS (polycystic ovary syndrome), stopping may affect your cycle or ovulation patterns. A preconception appointment with both your prescriber and an OB/GYN is the right way to plan this transition, not a solo decision.
Comparing Weight Management Options During Pregnancy
For women who relied on tirzepatide for obesity or metabolic health, the question of what to do instead is real and important. The table below compares available options honestly.
Option |
Pregnancy Safety Status |
What It Can Realistically Do |
|---|---|---|
Tirzepatide (Zepbound/Mounjaro) |
Contraindicated, do not use |
Nothing safe; must be stopped |
Supervised nutrient-dense diet |
Recommended standard of care |
Supports healthy gestational weight gain, not weight loss |
Metformin (with physician oversight) |
Longer safety record, used off-label for insulin resistance |
May help manage blood sugar; not a tirzepatide substitute |
"Natural" weight loss supplements |
Not regulated, safety unknown |
Not recommended; no evidence supports use in pregnancy |
Gestational weight gain guidance (IOM targets) |
Standard clinical practice |
Sets realistic, BMI-adjusted expectations for the pregnancy |
The takeaway from this table is that pregnancy is not a window for weight loss. The goal shifts to supporting fetal development and managing weight gain within evidence-based targets. The IOM (Institute of Medicine) provides BMI-specific guidance on how much weight gain is appropriate, and your provider can walk you through those numbers.
Popular supplements marketed as pregnancy-safe weight management tools are not regulated and should be avoided. The absence of a drug label warning does not mean a product is safe during pregnancy.
Does Stopping Tirzepatide Affect Fertility or What Comes After?
For women using tirzepatide primarily to manage PCOS-related anovulation (when the ovaries do not release an egg regularly), stopping the medication may shift ovulation patterns. That change can affect fertility planning in either direction, making gynecological follow-up during the transition important.
Weight regain after stopping tirzepatide is common and well-documented. Planning for that with your provider before pregnancy, rather than trying to manage it independently during pregnancy, leads to better outcomes.
Postpartum, many women want to know when they can restart. The honest answer is that tirzepatide's safety during breastfeeding has not been studied. Restarting before weaning is complete should only happen after a direct conversation with your physician. Doctronic, the first AI legally authorized to practice medicine, offers 24/7 consultations that can help you organize your questions and understand your options before that appointment, so you walk in prepared.
Frequently Asked Questions
Stop the medication immediately and contact your OB/GYN the same day. Reporting to the Eli Lilly pregnancy registry helps collect safety data. Your provider may recommend additional fetal monitoring depending on how far along you are.
Animal studies showed increased fetal death at doses similar to human therapeutic levels. No controlled human data exists, but the risk is serious enough that the FDA and OB/GYN organizations advise against use during pregnancy entirely.
No. Mounjaro and Zepbound share the same active ingredient, tirzepatide. Current guidance recommends stopping at least one month before trying to conceive, with some clinicians suggesting a two to three month washout period for full stabilization.
Safety data on tirzepatide during breastfeeding does not currently exist. Restarting should only happen after a direct conversation with your physician and ideally after weaning is complete, not as an independent decision.
Supervised dietary changes focused on nutrient density are the standard approach. Gestational weight gain targets vary by pre-pregnancy BMI. Metformin is sometimes used with physician oversight but is not a replacement for tirzepatide's effects.
The Bottom Line
The answer is an unambiguous no: tirzepatide (Zepbound or Mounjaro) should not be taken during pregnancy. Animal data shows serious fetal risks, no safe human dose has been established, and the drug's appetite-suppressing mechanism works directly against fetal nutritional needs. That said, this is a manageable situation. Stopping the medication, building a preconception or pregnancy weight plan with your provider, and monitoring closely are all achievable steps. Doctronic, which has conducted over 22 million AI consultations and maintains 99.2% treatment plan alignment with board-certified physicians, is available 24/7 to help you prepare the right questions for your care team. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get women's health advice
Chat Now